Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Subcutaneous infLammatory Response to Glucose Sensors: Impact on the Quality of the Measure

NCT05755243 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT05755243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05755243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Subcutaneous infLammatory Response to Glucose Sensors: Impact on the Quality of the Measure
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Completed
Start date
June 21, 2022
Completion date
September 20, 2023
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory response to glucose sensors